Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06055725 · ClinicalTrials.gov registry record
A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development
A clinical trial of Spasticity as Sequela of Stroke, sponsored by Ipsen.
- Recruiting
- Registry status
- 1,051
- Enrollment target
- 20
- Study locations
NCT06055725: Recruiting study of Spasticity as Sequela of Stroke, sponsored by Ipsen.
NCT06055725 is a study of Spasticity as Sequela of Stroke that is actively recruiting participants, run by Ipsen. The registered enrollment target is 1,051 participants. The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06055725, a study of Spasticity as Sequela of Stroke, is actively recruiting participants, sponsored by Ipsen.
- RECRUITING
- Registry status
- 1,051 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will monitor patients during the first year following their stroke. Stroke is a very serious condition where there is a sudden interruption of blood flow in the brain. The main aim of the study will be to find out how many of those who experience their first-ever stroke then go on to develop spasticity that would benefit from treatment with medication. Spasticity is a common post-stroke condition that causes stiff or ridged muscles. The results of this study will provide a standard guideline on the best way to monitor the development of post-stroke spasticity.
Primary Outcome
This is based on the investigator's clinical judgement and could include spasticity characterised by any of the following criteria aligned with the World Health Organization International Classification of Functioning, Disability and Health in three dimensions: Impairment, Activity limitations \& Restriction on participation.
Conditions Studied
Study Locations (20)
Texas
- The University Of Texas Southwestern Medical Center - Dallas
- McGovern Medical School - UT Physicians - Neurology (Adult Neurology Clinic) - Texas Medical Center Location - Houston
- The University of Texas Health Science Center - San Antonio
California
- Loma Linda - Anderson
- University Of California, Los Angeles Medical Center - Los Angeles
Florida
- University of South Florida (USF) - Morsani Center (USF Health Carol and Frank Morsani Center for Advanced Healthcare) - Florida City
- Knight Neurology - Rockledge
Massachusetts
- Massachusetts General Hospital - Boston
- Spaulding Rehabilitation Hospital - Boston
Nebraska
- Methodist Physicians Clinic - Omaha
- Madonna Rehabilitation Hospital - Omaha Campus - Omaha
Georgia
- Emory University Merge - Atlanta
Maryland
- Medstar Health Research Institute, Inc - Hyattsville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,051 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2027-11-30 |
What NCT06055725 shows while recruiting
NCT06055725 is an observational study that tracks outcomes without assigning an intervention. Its 1,051 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Spasticity as Sequela of Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT06055725 names 20 study sites across 14 states, led by Texas, California, Florida.
Frequently Asked Questions
What is clinical trial NCT06055725 about?
NCT06055725 is a clinical study titled "A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development". This study will monitor patients during the first year following their stroke. Stroke is a very serious condition where there is a sudden interruption of blood flow in the brain. The main aim of the study will be to find out how many of those who experience their first-ever stroke then go on to de...
What is the current status of trial NCT06055725?
This trial is currently recruiting. The enrollment target is 1,051 participants. The study started on 2023-11-01. Estimated completion is 2027-11-30.
What conditions does trial NCT06055725 study?
This clinical trial studies the following conditions: Spasticity as Sequela of Stroke.
Who is sponsoring clinical trial NCT06055725?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06055725 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spasticity as Sequela of Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
- NCT05915377 · 1,050 participants · NA
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI